Gene · 3777
Papers1,851
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,851
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dietary protein intake and the tubular handling of indoxyl sulfate. | Nephrol Dial Transplant | 2025 | 39354683 | PubTator, text mining | PubMed |
| The TWK-26/KCNK3 potassium channel and FLR-4 protein kinase coordinate nutrient absorption in the C. elegans intestine. | bioRxiv | 2025 | 38766028 | PubTator, text mining | PubMed |
| Intravenous anesthetics have differential effects on human potassium channels. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 40384046 | PubTator, text mining | PubMed |
| Identification of potential druggable targets for endometriosis through Mendelian randomization analysis. | Front Endocrinol (Lausanne) | 2024 | 39911230 | PubTator, text mining | PubMed |
| Dual disease co-expression analysis reveals potential roles of estrogen-related genes in postmenopausal osteoporosis and Parkinson's disease. | Front Genet | 2024 | 39840278 | PubTator, text mining | PubMed |
| Design of bisamide inhibitors of the TASK-1 potassium channel in silico. | Phys Chem Chem Phys | 2024 | 39651751 | PubTator, text mining | PubMed |
| Cross-Tissue Regulatory Network Analyses Reveal Novel Susceptibility Genes and Potential Mechanisms for Endometriosis. | Biology (Basel) | 2024 | 39596826 | PubTator, text mining | PubMed |
| Metabolomics-driven approaches for identifying therapeutic targets in drug discovery. | MedComm (2020) | 2024 | 39534557 | PubTator, text mining | PubMed |
| Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension. | Sci Rep | 2024 | 39523384 | PubTator, text mining | PubMed |
| Transcriptome analyses reveal common immune system dysregulation in PAH patients and Kcnk3-deficient rats. | Pulm Circ | 2024 | 39444497 | PubTator, text mining | PubMed |
| Integrative multi-omics summary-based mendelian randomization identifies key oxidative stress-related genes as therapeutic targets for atrial fibrillation and flutter. | Front Genet | 2024 | 39359474 | PubTator, text mining | PubMed |
| A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank. | Nat Commun | 2024 | 39278973 | PubTator, text mining | PubMed |
| Identification of potential therapeutic targets for nonischemic cardiomyopathy in European ancestry: an integrated multiomics analysis. | Cardiovasc Diabetol | 2024 | 39267096 | PubTator, text mining | PubMed |
| Proteome-wide mendelian randomization identifies therapeutic targets for nephrolithiasis. | Urolithiasis | 2024 | 39237840 | PubTator, text mining | PubMed |
| IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization. | Front Immunol | 2024 | 39229261 | PubTator, text mining | PubMed |
| Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization. | Front Pharmacol | 2024 | 39221148 | PubTator, text mining | PubMed |
| Ion occupancy of the selectivity filter controls opening of a cytoplasmic gate in the K2P channel TALK-2. | Nat Commun | 2024 | 39215031 | PubTator, text mining | PubMed |
| Potassium channel TASK-5 forms functional heterodimers with TASK-1 and TASK-3 to break its silence. | Nat Commun | 2024 | 39215006 | PubTator, text mining | PubMed |
| Causal gene identification using mitochondria-associated genome-wide mendelian randomization in atrial fibrillation. | Front Pharmacol | 2024 | 39135799 | PubTator, text mining | PubMed |
| Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia. | Circ Genom Precis Med | 2024 | 39119725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3777/papers?page=9